|
VPS29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.383730E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.389650E-01 |
| Normal-vs-Stage2 |
7.355200E-03 |
| Normal-vs-Stage3 |
9.039000E-03 |
| Normal-vs-Stage4 |
2.495400E-03 |
| Stage1-vs-Stage2 |
4.214300E-02 |
| Stage1-vs-Stage3 |
1.065190E-01 |
| Stage1-vs-Stage4 |
4.725500E-02 |
| Stage2-vs-Stage3 |
4.227800E-01 |
| Stage2-vs-Stage4 |
8.957000E-01 |
| Stage3-vs-Stage4 |
4.717400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.545600E-02 |
| Normal-vs-AfricanAmerican |
3.697600E-01 |
| Normal-vs-Asian |
2.195600E-02 |
| Caucasian-vs-AfricanAmerican |
7.328800E-01 |
| Caucasian-vs-Asian |
4.353600E-01 |
| AfricanAmerican-vs-Asian |
3.974000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.881600E-02 |
| Normal-vs-Female |
1.686100E-02 |
| Male-vs-Female |
9.815400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.919000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.156500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.741750E-03 |
| Normal-vs-Age(81-100Yrs) |
7.976400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.410200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.511720E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.159000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.847600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.805900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.434380E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.996200E-01 |
| Classical-VS-Follicular |
1.952430E-02 |
| Classical-VS-Other |
9.268200E-01 |
| Classical-VS-Normal |
1.958200E-01 |
| Tall-VS-Follicular |
2.023000E-01 |
| Tall-VS-Other |
9.822800E-01 |
| Tall-VS-Normal |
3.120600E-01 |
| Follicular-VS-Other |
5.070400E-01 |
| Follicular-VS-Normal |
3.256100E-03 |
| Other-VS-Normal |
5.097400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.257320E-03 |
| Normal-vs-N1 |
4.429700E-02 |
| N0-vs-N1 |
5.786200E-01 |
|
|
